School of Pharmacy, International Medical University (IMU), Kuala Lumpur, Malaysia.
School of Pharmacy, University of Otago, Dunedin, New Zealand.
Protein J. 2019 Oct;38(5):551-564. doi: 10.1007/s10930-019-09837-4.
Protein drugs are important therapeutic agents however; they may degrade during formulation processing. The objective of this study was to investigate the correlation between secondary structure alterations and the retentions of biological activity of protein upon the application of thermal stress. Catalase, horseradish peroxidase and α- chymotrypsin were employed as model proteins. Each protein was heated in a solid and solution state at a temperature of 70 °C for 1 h. Attenuated total reflectance Fourier transform infrared spectroscopy, size-exclusion chromatography and biological activity assay were performed. Results showed that heat-exposure of protein solids at 70 °C caused minimum changes in secondary structure and biological activity was almost retained. However, thermal exposure of protein aqueous solution induced significant changes in the secondary structure indicated by area overlap values and caused considerable reduction in the biological activity. The changes in secondary structures were found to be in full alignment with the loss of biological activity for both protein solids as well as aqueous solutions. Catalase lost entire biological activity upon heating in the solution state. In conclusion, the findings of the present study indicate a direct correlation between protein secondary structure alterations and the retention of biological activity which can be taken into account during the development and delivery of protein drugs formulations.
蛋白质药物是重要的治疗药物,但它们在制剂加工过程中可能会降解。本研究的目的是研究在热应力作用下,蛋白质二级结构变化与保留生物活性之间的相关性。本研究选用过氧化氢酶、辣根过氧化物酶和α-糜蛋白酶作为模型蛋白。将每种蛋白质分别在固体和溶液状态下于 70°C 加热 1 小时。采用衰减全反射傅里叶变换红外光谱、凝胶渗透色谱和生物活性测定法进行分析。结果表明,70°C 下加热蛋白质固体导致二级结构的最小变化,几乎保留了生物活性。然而,蛋白质水溶液的热暴露导致二级结构发生显著变化,表现为面积重叠值增加,并导致生物活性显著降低。对于蛋白质固体和水溶液,二级结构的变化与生物活性的丧失完全一致。过氧化氢酶在溶液状态下加热后完全丧失了生物活性。总之,本研究的结果表明,蛋白质二级结构的变化与生物活性的保留之间存在直接相关性,这在蛋白质药物制剂的开发和输送过程中应予以考虑。